Rachel Sealfon

Massachusetts Institute of Technology, Cambridge, MA, United States 
"Rachel Sealfon"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jungreis I, Sealfon R, Kellis M. (2020) SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Research Square
Iserman C, Roden C, Boerneke M, et al. (2020) Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. Biorxiv : the Preprint Server For Biology
Jungreis I, Sealfon R, Kellis M. (2020) Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations. Biorxiv : the Preprint Server For Biology
Dudas G, Carvalho LM, Bedford T, et al. (2017) Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature
Andersen KG, Shapiro BJ, Matranga CB, et al. (2015) Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 162: 738-50
Park DJ, Dudas G, Wohl S, et al. (2015) Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone. Cell. 161: 1516-26
Sealfon RS, Lin MF, Jungreis I, et al. (2015) FRESCo: finding regions of excess synonymous constraint in diverse viruses. Genome Biology. 16: 38
Kugelman JR, Sanchez-Lockhart M, Andersen KG, et al. (2015) Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. Mbio. 6
Kuhn JH, Andersen KG, Baize S, et al. (2014) Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 6: 4760-99
Schieffelin JS, Shaffer JG, Goba A, et al. (2014) Clinical illness and outcomes in patients with Ebola in Sierra Leone. The New England Journal of Medicine. 371: 2092-100
See more...